Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 1475 entries
View as:

A Retrospective, Observational Study on the Effectiveness of Daclatasvir-Containing Regimens in Patients in KSA, UAE and Qatar

Phase: N/A Priority: Normal
NCT ID: NCT03205618 Org: User:
Start: 04/26/16 End: 06/27/17 Due: 06/27/18

First Line Hepato Cellular Carcinoma (HCC)

Phase: N/A Priority: Normal
NCT ID: NCT00858871 Org: User:
Start: 05/31/09 End: 09/30/13 Due: 09/30/14

A Study to Evaluate the Effect of 2 Drugs on the Pharmacokinetics of BMS-986205 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03346837 Org: User:
Start: 11/22/17 End: 12/20/17 Due: 12/20/18

A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT06596642 Org: User:
Start: 08/21/24 End: 12/17/26 Due: 12/17/27

A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)

Phase: N/A Priority: Normal
NCT ID: NCT07004972 Org: User:
Start: 06/30/25 End: 12/13/27 Due: 12/13/28

A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT06723535 Org: User:
Start: 12/07/24 End: 10/17/25 Due: 10/17/26

Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-933043 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01605994 Org: User:
Start: 07/31/12 End: 12/31/13 Due: 12/31/14

Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00095550 Org: User:
Start: 10/31/04 End: 06/30/05 Due: 06/30/06

A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06946797 Org: User:
Start: 08/02/25 End: 10/25/28 Due: 10/25/29

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00729950 Org: User:
Start: 07/31/03 End: 06/30/07 Due: 06/30/08

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00035529 Org: User:
Start: 11/30/01 End: 12/31/03 Due: 12/31/04

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Phase: N/A Priority: Normal
NCT ID: NCT06504615 Org: User:
Start: 12/10/24 End: 08/31/28 Due: 08/31/29

Drug Interaction Study With a Potential Alzheimer's Disease Compound

Phase: N/A Priority: Normal
NCT ID: NCT00726726 Org: User:
Start: 08/31/08 End: 10/31/08 Due: 10/31/09

Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01775631 Org: User:
Start: 03/31/13 End: 08/31/16 Due: 08/31/17

A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00326131 Org: User:
Start: 04/30/06 End: - Due: -

A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea

Phase: N/A Priority: Normal
NCT ID: NCT06698887 Org: User:
Start: 09/11/24 End: 03/27/31 Due: 03/27/32

Study to Evaluate the Safety and Tolerability of IV Doses of BMS-906024 in Subjects With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01292655 Org: User:
Start: 03/03/11 End: 06/22/17 Due: 06/22/18

A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT05617677 Org: User:
Start: 01/12/23 End: 12/17/27 Due: 12/17/28

A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00644488 Org: User:
Start: 07/31/08 End: 03/31/09 Due: 03/31/10

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00116116 Org: User:
Start: 03/31/02 End: 06/30/05 Due: 06/30/06

Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules

Phase: N/A Priority: Normal
NCT ID: NCT03509883 Org: User:
Start: 04/26/18 End: 06/15/18 Due: 06/15/19

Trial of BMS-986012 in Combination With Platinum and Etoposide

Phase: N/A Priority: Normal
NCT ID: NCT02815592 Org: User:
Start: 11/28/16 End: 08/06/24 Due: 08/06/25

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00095173 Org: User:
Start: 12/31/03 End: 11/30/11 Due: 11/30/12

A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05337137 Org: User:
Start: 05/05/22 End: 12/15/26 Due: 12/15/27

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT01752985 Org: User:
Start: 03/18/13 End: 06/30/15 Due: 06/30/16